Quantcast

PENNSYLVANIA RECORD

Sunday, May 5, 2024

U.S. District Court for the Eastern District of Pennsylvania: Actions Taken on Jan. 7

Filings

The U.S. District Court for the Eastern District of Pennsylvania reported the following activity on Jan. 7 in the suits below:

In Briana Smith against Corporate President Bishop Church of Jesus Christ LDS: 'Notice Of Removal By Corporate President Bishop Church Of Jesus Christ Lds (filing Fee $ 402 Receipt Number 0313-14826606), Filed By Corporate President Bishop Church Of Jesus Christ Lds.(feigenbaum, Joel)'

Case number 2:21-cv-00072 was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Jill Lafaw against Standard Insurance Company: 'Complaint Against Standard Insurance Company ( Filing Fee $ 402 Receipt Number 0313-14827350.), Filed By Jill Lafaw. (attachments: # 1 Designation Form, # 2 Civil Cover Sheet, # 3 Case Management Track Form)(parker, Michael)'

Case number 5:21-cv-00079-JFL was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Teresa J. Edwards against American Regent Inc., Daiichi Sankyo Inc., Daiichi Sankyo US Holdings Inc., Luitpold Pharmaceuticals Inc., Relypsa Inc., Vifor (International) Ag, Vifor Pharma Ltd. and Vifor Pharma Participations Ltd.: 'Complaint Against All Defendants ( Filing Fee $ 402 Receipt Number 0313-14825970.), Filed By Teresa J. Edwards. (attachments: # 1 Civil Cover Sheet, # 2 Designation Form, # 3 Case Management Track Form)(kessler, Rayna)'

Case number 2:21-cv-00067 was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Pamela Jo Peters and Robert Peters against Mckesson Corp., Merck & Co. Inc. and Merck Sharp & Dohme Corp.: 'Complaint Against All Defendants ( Filing Fee $ 402 Receipt Number 0313-14826285.), Filed By Pamela Jo Peters, Robert Peters. (attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Certificate Of Service Merck & Co. Inc. /pos, # 3 Certificate Of Service McKesson Corp./pos, #4 Certificate Of Service Merck Sharp And Dohme Corp./Pos, # 5 Case Management Track Form Case Management Track Form, # 6 Designation Form Designation Form)(humphrey, Debra)'

Case number 2:21-cv-00068 was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Toni Mitchell against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC. D B a Teva Women's Health, INC., Teva Pharmaceutical USA Inc., Teva Women's Health Inc. Individually, and, Teva Women's Health LLC, Individually and and The Cooper Companies Inc.:

'Notice Of Removal By Coopersurgical, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., The Cooper Companies, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Pharmaceutical Usa, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc. (filing Fee $ 402 Receipt Number 0313-14825370), Filed By Coopersurgical, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., The Cooper Companies, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Pharmaceutical Usa, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc..(rubenstein, Brian) Modified On 1/7/2021 (lisad, ).'

'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc. (rubenstein, Brian) Modified On 1/7/2021 (lisad, ).'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceutical Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health, Inc. Individually, And As Successor In Interest To Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Coopersurgical, Inc..(rubenstein, Brian)'

'Answer To Complaint By The Cooper Companies, Inc. (rubenstein, Brian) Modified On 1/7/2021 (lisad, ).'

'Answer To Complaint By Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:21-cv-00064-HB was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Iris Crespo against Magnum Opus Federal Corp.:

'Complaint Against Magnum Opus Federal Corporation ( Filing Fee $ 402 Receipt Number 0313-14827108.), Filed By Iris Crespo. (attachments: # 1 Civil Cover Sheet, # 2 Case Management Track Form, # 3 Designation Form)(rooks, Franklin) Modified On 1/7/2021 (lisad, ).'

'Demand For Trial By Jury By Iris Crespo. (lisad, )'

'Summons Issued As To Magnum Opus Federal Corporation. Emailed To: Counsel On 1/7/21 (jaa, )'

Case number 2:21-cv-00074-CFK was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Thomas P. Williams against State Farm: 'Initial Procedural Order.. Signed By Honorable Joseph F. Leeson, Jr On 1/7/21. 1/7/21 Entered And Copies E-mailed.(dt, )'

Case number 5:21-cv-00058-JFL was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Carrie Diehl against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC. D B a Teva Women's Health, INC., THE Cooper Companies Inc., Teva Pharmaceutical, USA Inc., Teva Women's Health Inc., Individually, and and Teva Women's Health LLC, Individually and:

'Notice Of Removal By Coopersurgical, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., The Cooper Companies, Inc, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Pharmaceutical, Usa, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc. (filing Fee $ 402 Receipt Number 0313-14827048), Filed By Coopersurgical, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., The Cooper Companies, Inc, Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Pharmaceutical, Usa, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceutical, Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Coopersurgical, Inc..(rubenstein, Brian)'

'Answer To Complaint By The Cooper Companies, Inc.(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:21-cv-00075 was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Erica Tucker against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC., D B a Teva Women's Health, INC., Teva Branded Pharmaceutical Products R&D Inc., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc., Individually, and, Teva Women's Health LLC, Individually and and The Cooper Companies Inc.:

'Notice Of Removal By Teva Branded Pharmaceutical Products R&d, Inc., Coopersurgical, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., The Cooper Companies, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Pharmaceuticals Usa, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc. (filing Fee $ 402 Receipt Number 0313-14827989), Filed By Teva Branded Pharmaceutical Products R&d, Inc., Coopersurgical, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., The Cooper Companies, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Pharmaceuticals Usa, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Branded Pharmaceutical Products R&d, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:21-cv-00085 was filed in the U.S. District Court for the Eastern District of Pennsylvania.

In Jessica Zuniga and Rodolfo Zuniga against Westfield Insurance: 'Notice Of Removal By Westfield Insurance (filing Fee $ 402 Receipt Number 0313-14825664), Filed By Westfield Insurance.(thrall, William)'

Case number 2:21-cv-00066 was filed in the U.S. District Court for the Eastern District of Pennsylvania.

More News